Perspective Therapeutics (CATX) Non-Current Deferred Tax Liability (2023 - 2026)

Perspective Therapeutics (CATX) has 4 years of Non-Current Deferred Tax Liability data on file, last reported at $1.7 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Deferred Tax Liability fell 31.78% year-over-year to $1.7 million; the trailing twelve-month figure through Mar 2026 stood at $1.7 million (down 31.78% YoY), and the FY2025 full-year result was $1.7 million, down 31.78% from the prior year.
• Non-Current Deferred Tax Liability steadied at $1.7 million in Q1 2026, from $1.7 million in the prior quarter.
• In the past five years, Non-Current Deferred Tax Liability ranged from a high of $4.6 million in Q4 2023 to a low of $1.7 million in Q4 2025.
• A 4-year average of $3.2 million and a median of $2.5 million in 2024 frame the typical range for Non-Current Deferred Tax Liability.
• Across the five-year window, Non-Current Deferred Tax Liability slumped 45.67% in 2024 and sank 31.78% in 2025, its largest moves.
• Tracing CATX's Non-Current Deferred Tax Liability over 4 years: stood at $4.6 million in 2023, then tumbled by 45.67% to $2.5 million in 2024, then tumbled by 31.78% to $1.7 million in 2025, then changed by 0.0% to $1.7 million in 2026.
• Business Quant data shows CATX's Non-Current Deferred Tax Liability at $1.7 million in Q1 2026, $1.7 million in Q4 2025, and $2.5 million in Q3 2025.